Dr. Maureen Hewitt, MD
Claim this profileChester County Hospital
Studies Breast Cancer
Studies Breast cancer
12 reported clinical trials
24 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage II
Stage III
2Breast Cancer
HER2 positive
Stage II
ER positive
Affiliated Hospitals
Clinical Trials Maureen Hewitt, MD is currently running
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting2 awards Phase 3
More about Maureen Hewitt, MD
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Maureen Hewitt, MD has experience with
- Paclitaxel
- Trastuzumab
- Pertuzumab
- Pembrolizumab
- Chemotherapy
- NTproBNP Guided Strategy Of Cardioprotection
Breakdown of trials Maureen Hewitt, MD has run
Breast Cancer
Breast cancer
Endometrial Adenocarcinoma
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maureen Hewitt, MD specialize in?
Maureen Hewitt, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage II.
Is Maureen Hewitt, MD currently recruiting for clinical trials?
Yes, Maureen Hewitt, MD is currently recruiting for 6 clinical trials in West Chester Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Maureen Hewitt, MD has studied deeply?
Yes, Maureen Hewitt, MD has studied treatments such as Paclitaxel, Trastuzumab, Pertuzumab.
What is the best way to schedule an appointment with Maureen Hewitt, MD?
Apply for one of the trials that Maureen Hewitt, MD is conducting.
What is the office address of Maureen Hewitt, MD?
The office of Maureen Hewitt, MD is located at: Chester County Hospital, West Chester, Pennsylvania 19380 United States. This is the address for their practice at the Chester County Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.